Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC), and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), are specialist options for selected patients with peritoneal spread of cancer.
Selected patients with peritoneal spread from ovarian, colorectal, appendiceal or gastric cancer
Patients with disease confined enough for complete cytoreduction to be realistic
Patients for whom PIPAC may help control symptoms or disease when CRS-HIPEC is not suitable
The Treatment Journey
01
Evaluation
Imaging and, where needed, diagnostic laparoscopy to assess peritoneal disease extent.
02
Multidisciplinary review
A tumour board discussion confirms candidacy for CRS-HIPEC or PIPAC.
03
Surgery
Cytoreductive surgery removes visible disease, followed by heated intraperitoneal chemotherapy where indicated.
04
Recovery & follow-up
A structured recovery plan with monitoring for recurrence.
Benefits & Limitations
CRS-HIPEC is a major undertaking suited to carefully selected patients; PIPAC is a less invasive, repeatable option for a different group of patients. An honest evaluation determines which — if either — applies.